Related Experiment Video
Updated: May 19, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Generation and characterization of novel cytochrome P450 Cyp2c gene cluster knockout and CYP2C9 humanized mouse lines
Nico Scheer1, Yury Kapelyukh, Lynsey Chatham
1TaconicArtemis, Koeln, Germany. nico.scheer@taconicartemis.com
Abstract:
Compared with rodents and many other animal species, the human cytochrome P450 (P450) Cyp2c gene cluster varies significantly in the multiplicity of functional genes and in the substrate specificity of its enzymes. As a consequence, the use of wild-type animal models to predict the role of human CYP2C enzymes in drug metabolism and drug-drug interactions is limited. Within the human CYP2C cluster CYP2C9 is of particular importance, because it is one of the most abundant P450 enzymes in human liver, and it is involved in the metabolism of a wide variety of important drugs and environmental chemicals. To investigate the in vivo functions of cytochrome P450 Cyp2c genes and to establish a model for studying the functions of CYP2C9 in vivo, we have generated a mouse model with a deletion of the murine Cyp2c gene cluster and a corresponding humanized model expressing CYP2C9 specifically in the liver. Despite the high number of functional genes in the mouse Cyp2c cluster and the reported roles of some of these proteins in different biological processes, mice deleted for Cyp2c genes were viable and fertile but showed certain phenotypic alterations in the liver. The expression of CYP2C9 in the liver also resulted in viable animals active in the metabolism and disposition of a number of CYP2C9 substrates. These mouse lines provide a powerful tool for studying the role of Cyp2c genes and of CYP2C9 in particular in drug disposition and as a factor in drug-drug interaction.
Insights
Human cytochrome P450 (CYP450) gene clusters differ from rodents, limiting animal models for drug metabolism studies. New mouse models with Cyp2c gene deletion and humanized CYP2C9 expression offer powerful research tools.
Area of Science:
- Pharmacology
- Genetics
- Biochemistry
Background:
- Human cytochrome P450 (CYP450) Cyp2c gene clusters exhibit significant variation in gene number and enzyme substrate specificity compared to other species.
- This variability limits the predictive accuracy of traditional animal models for human CYP2C enzyme activity in drug metabolism and drug-drug interactions.
- Human CYP2C9 is a key enzyme in liver metabolism for numerous drugs and environmental chemicals.
Purpose of the Study:
- To investigate the in vivo functions of cytochrome P450 Cyp2c genes.
- To develop a mouse model for studying CYP2C9 function in vivo.
- To create a humanized mouse model expressing CYP2C9 specifically in the liver.
Main Methods:
- Generation of a mouse model with a deletion of the entire murine Cyp2c gene cluster.
- Development of a corresponding humanized mouse model expressing human CYP2C9 in the liver.
- Phenotypic analysis of mice with Cyp2c gene deletion and humanized CYP2C9 expression.
Main Results:
- Mice with Cyp2c gene cluster deletion were viable and fertile, exhibiting specific liver phenotypic alterations.
- The humanized mouse model successfully expressed CYP2C9 in the liver.
- The humanized mice demonstrated activity in the metabolism and disposition of CYP2C9 substrates.
Conclusions:
- The generated mouse lines are valuable tools for studying Cyp2c gene functions in vivo.
- These models are crucial for understanding the role of CYP2C9 in drug disposition and drug-drug interactions.
- The models facilitate research into species-specific differences in drug metabolism.
Related Concept Videos
In-vitro Mutagenesis
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

